Back

Five-year outcomes after first- or second-generation drug-eluting stent implantation in all-comer patients undergoing percutaneous coronary intervention

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - PCI - Restenosis Restenosis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Hideki Yano

Ohtawara Redcross Hospital, Odawara (Japan)

11 More presentations in this session

Presentation thumbnail
Doctor M. Abe (Kurashiki, JP)
Abstract
Presentation thumbnail
Doctor Y. Sanuki (Kitakyusyu, JP)
Abstract Slides
Presentation thumbnail
Miss Y. Wang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Doctor I. Bossi (Milano, IT)
Abstract Slides
Presentation thumbnail
Mr H. Watanabe (Wakayama, JP)

Access the full session

Session thumbnail
Poster session 1 - PCI - Restenosis

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials
28 August 2020
thumbnail
Congress Presentation
Five-year outcomes after left main PCI stratified by procedural urgency
21 March 2026
thumbnail
Congress Presentation
Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation
2 September 2024
thumbnail
Congress Presentation
Second-generation drug-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated lesion in the proximal left anterior descending artery
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources